Application Deadline: Monday, April 8, 2024 | 11:59 pm Apply View Request for Applications For questions, please contact Patrick Shea at [email protected].
A novel three-drug combination achieved notable responses in patients with advanced HER2-negative breast cancer, according to new research directed by investigators from the Johns Hopkins Kimmel…
The Research Navigators regularly receive questions covering a wide range of topics about conducting research studies at Johns Hopkins. It is not uncommon for multiple…
Findings from recent investigation suggest physicians can feel confident prescribing treatment based on results from patient-reported, self-administered tests In a study involving nearly 1,000 patients…
Researchers used genetic markers in maternal blood that serve as “stand-ins” for brain molecules Researchers in a Johns Hopkins Children’s Center-led study that used genetic…
Application Deadline: Monday, March 11, 2024 | 5:00 pm EST Request for Applications The milestone driven Accelerated Translational Incubator Pilot (ATIP) Program provides awards ranging in…
This article discusses the work of Jacky Jennings, PhD, MPH, BIRCWH Award program mentor. Across the United States, a growing number of families with low…
A combination of two cancer drugs could be effective against malignant peripheral nerve sheath tumors (MPNSTs) — soft tissue tumors that are stubbornly resistant to…
An international academic consortium has identified 13 biomarkers that significantly improve the ability to accurately predict cardiovascular disease risk in people with type 2 diabetes.…
Johns Hopkins neuroscientists show how specialized cells signal the presence of light simultaneously in two distinct ways Working with mammalian retinal cells, neuroscientists at Johns…